Clinical trial
Lycopene in Treating Patients With Prostate Cancer or Benign Prostatic…
NCT00416390 · University of Illinois at Chicago, Other · Completed
Key facts
| NCT number | NCT00416390 |
|---|---|
| Title | Lycopene in Treating Patients With Prostate Cancer or Benign Prostatic Hyperplasia |
| Official title | The Effect of Lycopene on DNA Damage in Human Prostate |
| Lead sponsor | University of Illinois at Chicago, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Nonmalignant Neoplasm, Prostate Cancer |
| Intervention type | Dietary Supplement, Other, Procedure |
| Interventions | lycopene, laboratory biomarker analysis, biopsy |
| Enrollment | 120 |
| Completion | Mar 1, 2011 |
| First posted | Dec 28, 2006 |
| Last update posted | Sep 20, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: